Harvard Apparatus Regenerative Technology, Inc. (HRGN) shareholders
Close on Oct 19, 2026Market cap $38.92MP/E –Yield –
Ownership
Who owns Harvard Apparatus Regenerative Technology's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bin Zhao Joint filing with DST Capital LLC (25.70%) | 3,756,547 | 25.90% | 13D (active) amendment | Jul 8, 2024 |
| Stellars Capital Private I Limited | 2,113,784 | 13.30% | 13D (active) | Aug 26, 2024 |
| Harvard Bioscience, Inc. | 697,112 | 5.00% | 13G (passive) amendment | Jan 9, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Junli He | CEO, Director | 1,332,930 | 7.58% | Sep 25, 2026 |
| David Green | Director | 175,329 | 1.00% | Jul 1, 2025 |
| Ronald J. Packard | Director | – | – | Jul 1, 2025 |
| James E. Shmerling | Director | 23,756 | 0.14% | Jul 1, 2025 |
| Jing Chen | Director | 210,000 | 1.19% | Jul 1, 2025 |
| Ting Li | Director | – | – | Jul 1, 2025 |
| Herman Sanchez | Director | – | – | Jul 1, 2025 |
| Mao Zhang | Director | 2,113,784 | 12.02% | Jul 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Junli He CEO, Director | Sep 15, 2026 | Buy | +6,725 | $2.15 | $14.46K | 1,332,930 |
| Junli He CEO, Director | Sep 11, 2026 | Conversion | +683,725 | $1.05 | $717.91K | 964,300 |
| Junli He CEO, Director | Sep 11, 2026 | Buy | +361,905 | $1.05 | $380.00K | 1,326,205 |
| Junli He CEO, Director | Nov 25, 2025 | Buy | +3,000 | $1.70 | $5.10K | 280,575 |
| Junli He CEO, Director | Sep 30, 2025 | Buy | +300 | $1.98 | $594 | 277,575 |
| Junli He CEO, Director | Sep 2, 2025 | Buy | +11,225 | $1.85 | $20.77K | 277,275 |
| Junli He CEO, Director | Aug 21, 2025 | Buy | +4,050 | $1.72 | $6.97K | 266,050 |
| Junli He CEO, Director | Dec 24, 2024 | Buy | +2,299 | $2.87 | $6.60K | 262,000 |
| Junli He CEO, Director | Aug 27, 2024 | Buy | +5,101 | $3.37 | $17.19K | 259,701 |
| Junli He CEO, Director | Jun 21, 2024 | Buy | +1,600 | $2.80 | $4.48K | 254,600 |
| Junli He CEO, Director | Dec 27, 2023 | Buy | +2,700 | $4.76 | $12.85K | 253,000 |
| Junli He CEO, Director | Dec 14, 2023 | Buy | +900 | $4.92 | $4.43K | 250,300 |
| Junli He CEO, Director | Dec 6, 2023 | Buy | +1,500 | $5.07 | $7.61K | 249,400 |
| Junli He CEO, Director | Sep 11, 2023 | Buy | +1,500 | $5.43 | $8.15K | 247,900 |
| Junli He CEO, Director | Aug 28, 2023 | Buy | +3,400 | $4.69 | $15.95K | 246,400 |
| James E. Shmerling Director | Aug 21, 2023 | Buy | +6,864 | $4.35 | $29.86K | 23,756 |
| Junli He CEO, Director | Aug 18, 2023 | Buy | +8,000 | $4.32 | $34.56K | 243,000 |
| Capital LLC DST 10% owner | Apr 6, 2023 | Buy | +62,500 | $6.00 | $375.00K | 3,725,825 |
| Junli He Director | Dec 12, 2022 | Sale | −135 | $6.83 | $922 | 235,000 |
| Jing Chen Director | Dec 7, 2022 | Option exercise | +174,000 | $2.00 | $348.00K | 210,000 |
| Jing Chen Director | Dec 7, 2022 | Sale | −48,532 | $7.17 | $347.97K | 161,468 |
| Capital LLC DST 10% owner | Dec 7, 2022 | Sale | −1,952 | $7.17 | $14.00K | 3,663,325 |
| Capital LLC DST 10% owner | Dec 7, 2022 | Option exercise | +7,000 | $2.00 | $14.00K | 3,665,277 |
| Hong Yu PRESIDENT | Dec 7, 2022 | Sale | −83,676 | $7.17 | $599.96K | 222,459 |
| Hong Yu PRESIDENT | Dec 7, 2022 | Option exercise | +300,000 | $2.00 | $600.00K | 306,135 |
| James E. Shmerling Director | May 12, 2022 | Buy | +16,892 | $5.92 | $100.00K | 16,892 |
| David Green Interim CEO, Director | May 12, 2022 | Buy | +63,345 | $5.92 | $375.00K | 158,861 |
| Capital LLC DST 10% owner | May 12, 2022 | Buy | +8,277 | $5.92 | $49.00K | 3,658,277 |
| David Green Interim CEO, Director | Nov 26, 2021 | Buy | +72,464 | $3.45 | $250.00K | 95,516 |
| Capital LLC DST 10% owner | Sep 1, 2021 | Buy | +500,000 | $2.00 | $1.00M | 3,650,000 |
| Capital LLC DST 10% owner | Jun 17, 2021 | Buy | +150,000 | $2.00 | $300.00K | 3,150,000 |
| Peter M. Chakoutis Vice President of Finance | May 14, 2020 | Tax withholding | −2,845 | $3.13 | $8.90K | 23,793 |
| Peter M. Chakoutis Vice President of Finance | May 14, 2020 | Award | +10,000 | – | – | 26,638 |
| Peter M. Chakoutis Vice President of Finance | Apr 28, 2020 | Award | +10,000 | – | – | 19,795 |
| Peter M. Chakoutis Vice President of Finance | Apr 28, 2020 | Tax withholding | −3,157 | $3.05 | $9.63K | 16,638 |
| Peter M. Chakoutis Vice President of Finance | Mar 27, 2020 | Tax withholding | −5,205 | $4.00 | $20.82K | 9,795 |
| Peter M. Chakoutis Vice President of Finance | Mar 27, 2020 | Award | +15,000 | – | – | 15,000 |
| Jeffrey E. Young Director | Sep 30, 2019 | Option exercise | +25,000 | $2.00 | $50.00K | 25,000 |
| Capital LLC DST 10% owner | May 3, 2019 | Option exercise | +250,000 | $2.00 | $500.00K | 3,000,000 |
| Capital LLC DST 10% owner | Apr 24, 2019 | Option exercise | +250,000 | $2.00 | $500.00K | 2,750,000 |
| Capital LLC DST 10% owner | Jan 31, 2019 | Option exercise | +500,000 | $2.00 | $1.00M | 2,500,000 |
| Capital LLC DST 10% owner | Jul 12, 2018 | Buy | +5,000 | $4.00 | $20.00K | 30,722 |
| Jing Chen Director | Jun 29, 2018 | Conversion | +27,000 | – | – | 36,000 |
| Capital LLC DST 10% owner | Jun 29, 2018 | Conversion | +1,500,000 | – | – | 2,000,000 |
| Xiaoyu Du 10% owner | Jun 29, 2018 | Buy | +250,000 | $3.60 | $900.00K | 750,000 |
| Thomas McNaughton Chief Financial Officer | Jun 15, 2018 | Buy | +2,500 | $4.40 | $11.00K | 13,734 |
| Hong Yu President | Jun 15, 2018 | Buy | +4,705 | $4.50 | $21.17K | 44,520 |
| Hong Yu President | Jun 14, 2018 | Buy | +14,645 | $4.39 | $64.29K | 39,815 |
| Hong Yu President | Jun 13, 2018 | Buy | +650 | $3.75 | $2.44K | 25,170 |
| Hong Yu President | Jun 12, 2018 | Buy | +22,000 | $3.82 | $84.04K | 24,520 |
| James Joseph McGorry Chief Executive Officer, Director | Jun 12, 2018 | Buy | +2,100 | $4.00 | $8.40K | 10,065 |
| Thomas H. Robinson Director | Mar 14, 2018 | Option exercise | +912 | – | – | 3,412 |
| James Joseph McGorry Chief Executive Officer, Director | Mar 14, 2018 | Option exercise | +1,650 | – | – | 7,965 |
| John J. Canepa Director | Mar 14, 2018 | Option exercise | +912 | – | – | 1,774 |
| Blaine H. McKee Director | Mar 14, 2018 | Option exercise | +912 | – | – | 912 |
| Thomas McNaughton Chief Financial Officer | Mar 14, 2018 | Option exercise | +928 | – | – | 11,234 |
| Capital LLC DST 10% owner | Feb 28, 2018 | Buy | +10,000 | $3.26 | $32.60K | 25,722 |
| Capital LLC DST 10% owner | Jan 22, 2018 | Buy | +1,572 | $2.67 | $4.20K | 15,722 |
| Capital LLC DST 10% owner | Jan 19, 2018 | Buy | +3,700 | $2.60 | $9.62K | 14,150 |
| Capital LLC DST 10% owner | Jan 17, 2018 | Buy | +5,000 | $2.20 | $11.00K | 10,450 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Harvard Apparatus Regenerative Technology's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?